Company Valuation: Healthlead

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025
Market Cap 1 4,923 6,691 2,829 2,774 1,886
Change - 35.91% -57.72% -1.92% -32.02%
Enterprise Value (EV) 1 4,332 6,205 2,495 2,554 1,655
Change - 43.25% -59.79% 2.37% -35.2%
P/E 46.9x 56.6x 37.9x 35.4x 24.8x
PBR 5.69x 7.1x 2.92x 2.76x 1.95x
PEG 2.3x 4.5x -1x 7.37x 31.41x
Capitalization / Revenue 4.05x 4.35x 1.7x 1.38x 0.83x
EV / Revenue 3.56x 4.03x 1.5x 1.27x 0.73x
EV / EBITDA 37x 38.1x 19.8x 19.5x 10.8x
EV / EBIT 42.2x 41.8x 24.8x 26.8x 15x
EV / FCF 87.9x -737x -156x 830x 11.7x
FCF Yield 1.14% -0.14% -0.64% 0.12% 8.55%
Dividend per Share 2 0.28 0.18 0.15 0.17 0.22
Rate of return 1.55% 0.73% 1.44% 1.67% 3.06%
EPS 2 0.3861 0.4347 0.2746 0.2877 0.29
Distribution rate 72.5% 41.4% 54.6% 59.1% 75.9%
Net sales 1 1,216 1,538 1,659 2,011 2,270
EBITDA 1 117.1 163 126.3 131.3 153.5
EBIT 1 102.6 148.4 100.7 95.39 110.6
Net income 1 79.66 118.2 74.68 78.26 77.86
Net Debt 1 -591.5 -486 -333.6 -220.1 -230.9
Reference price 2 18.100 24.600 10.400 10.200 7.200
Nbr of stocks (in thousands) 272,000 272,000 272,000 272,000 261,956
Announcement Date 25/02/22 27/02/23 28/02/24 28/02/25 25/02/26
1THB in Million2THB
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 41.29M
17.8x0.75x11.16x-.--% 15.82B
21.72x0.84x14.15x1.03% 6.71B
16.33x0.74x7.74x2.28% 6.26B
14.97x0.98x7.08x2.83% 4.32B
14.47x1.24x7.6x5.56% 3.22B
13.74x0.56x4.49x5.03% 3.03B
14.36x0.86x6.5x4.47% 3.03B
30.93x - - - 2.41B
Average 18.04x 0.85x 8.39x 3.03% 4.98B
Weighted average by Cap. 17.87x 0.82x 9.63x 1.89%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. HL Stock
  4. Valuation Healthlead